Therefore, we reasoned that it is unlikely the upregulation of the stemness factors Oct3/4, Nanog, CD44 and CD90 in these prostate cancer cell lines was through AR, since similar results were also observed in the AR-negative PC-3 cells. This evidence concerns the gene POU5F1 and prostate cancer.